NCT02713711 Effectiveness of Artificial Balneotherapy, Phototherapy and Artificial Balneophototherapy in the Treatment of Psoriasis Status COMPLETED Phase NA
NCT02701205 Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis Status UNKNOWN Phase PHASE3
NCT02698475 An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age Status COMPLETED Phase PHASE3
NCT02694523 BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02690142 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035 Status COMPLETED Phase PHASE1
NCT02684370 BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02684357 BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02672852 BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment Status COMPLETED Phase PHASE3
NCT02668341 Cross Sectional Analysis of Healthcare for Psoriasis in 4 European Countries Status UNKNOWN Phase N/A
NCT02652494 Observational Study of Apremilast in Patients With Psoriasis in The Netherlands Status COMPLETED Phase N/A
NCT02652065 Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis Status COMPLETED Phase NA
NCT02649270 Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis Status TERMINATED Phase PHASE1
NCT02644954 Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis Status UNKNOWN Phase PHASE3
NCT02635204 A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02630901 Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis Status COMPLETED Phase PHASE1
NCT02626793 A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions Status COMPLETED Phase N/A